UBS Group »

Maravai Lifesciences Holdings shares owned by UBS Group

Quarter-by-quarter ownership of Maravai Lifesciences Holdings (MRVI) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Maravai Lifesciences Holdings

Tip: Access up to 7 years of quarterly data

All positions including Maravai Lifesciences Holdings held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maravai Lifesciences Holdings by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 154k 6.55
2023-09-30 $573k 57k 10.00
2023-06-30 $1.8M 142k 12.43
2023-03-31 $1.6M 114k 14.01
2022-12-31 $1.3M 91k 14.31
2022-09-30 $2.2M 84k 25.65
2022-06-30 $2.6M 93k 28.41
2022-03-31 $3.6M 101k 35.41
2021-12-31 $5.1M 122k 41.90
2021-09-30 $6.8M 139k 49.08
2021-06-30 $6.3M 151k 41.73
2021-03-31 $2.5M 70k 35.64
2020-12-31 $1.0M 36k 28.04

More positions owned by UBS Group

Microsoft Corporation (MSFT)
Apple Call Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
NVIDIA Corporation (NVDA)
Ubs Group SHS (UBS)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A (META)

View all positions for UBS Group

Top funds holding Maravai Lifesciences Holdings

12 West Capital Management
Vanguard Group
Massachusetts Financial Services
Millennium Management
Mackenzie Financial
Braidwell
AQR Capital Management
Alyeska Investment Group
Pacer Advisors
Marshall Wace
Point72 Europe
Hudson Bay Capital Management
Bamco
Two Sigma Advisers
Deutsche Bank Aktiengesellschaft

View all funds holding Maravai Lifesciences Holdings